CRPS and RSD Medication Protocols in Personal Injury Cases

James Wong — Founder & Pharmacist, LienScripts | October 17, 2024 | 8 min read

Complex Regional Pain Syndrome (CRPS) and Reflex Sympathetic Dystrophy (RSD) are serious, often disabling conditions that can develop after personal injury. The medication protocols are complex, the cases are high-value, and pharmacy lien coverage is essential for maintaining the treatment required to build a complete case record.

[!KEY] CRPS is one of the most significant injury complications in personal injury law — the multi-drug medication protocol (gabapentinoids, SNRIs, bisphosphonates, topical ketamine) and the extended treatment timeline create a pharmacy record that is among the strongest available evidence for the high-value damages these cases command.

What Is CRPS/RSD?

Complex Regional Pain Syndrome (CRPS), previously called Reflex Sympathetic Dystrophy (RSD), is a chronic pain condition characterized by severe, burning pain that is disproportionate to the initiating injury, accompanied by changes in skin color, temperature, and texture, as well as swelling, motor dysfunction, and extreme sensitivity.

CRPS can develop after a personal injury — a fracture, crush injury, sprain, or even a relatively minor trauma — and represents one of the most significant injury complications in PI cases. CRPS is:

• Difficult to diagnose: It requires specialist evaluation and is frequently missed in the early stages
• Expensive to treat: The medication protocols are complex and multi-drug
• Disabling: Severe CRPS can be career-ending and life-altering
• High-value: CRPS cases routinely settle in the mid-to-high six figures or more

For PI attorneys, CRPS is one of the most important injury categories to understand from a medication perspective — both because proper treatment is clinically essential and because the pharmacy record in a CRPS case is powerful evidence.

CRPS Medication Protocols

CRPS is treated with a multi-modal approach involving multiple drug classes simultaneously:

Neuropathic agents (central to CRPS treatment):

• Gabapentin and pregabalin are foundational in CRPS management — they address the central sensitization that characterizes the condition. Doses used in CRPS are typically higher than those used for post-injury nerve pain.
• Duloxetine or other SNRIs may be added for their combined neuropathic and mood effects.

Corticosteroids (early phase):

• Short-course steroids (prednisone, methylprednisolone) may be prescribed in the acute phase when inflammatory and vasomotor features are prominent.

Bisphosphonates:

• Medications typically used for osteoporosis (alendronate, risedronate) have evidence for reducing CRPS pain in some patients and may be prescribed by CRPS specialists.

Alpha-2 agonists:

• Clonidine (oral or transdermal patch) has sympatholytic effects that may benefit CRPS patients with significant sympathetically-mediated pain.

Topical agents:

• Lidocaine patches and cream: For localized allodynia (pain from non-painful stimuli)
• Ketamine cream: Compound formulations with sub-anesthetic ketamine are used by some CRPS specialists for localized treatment
• Dimethyl sulfoxide (DMSO) cream: Used in some European protocols, occasionally in the US

Opioids:

• Low-to-moderate dose opioids may be used as part of a comprehensive pain management plan for CRPS patients with severe pain — though the evidence for opioid benefit in CRPS is mixed, and prescribing is typically conservative

Antidepressants:

• TCAs (amitriptyline, nortriptyline) for their neuropathic pain and sleep benefits
• SSRIs/SNRIs for comorbid depression, which is nearly universal in severe CRPS

Why CRPS Cases Need Pharmacy Lien Coverage

The medication complexity in CRPS cases means:

1. Multiple concurrent prescriptions from specialists (pain management, neurology) and the treating physician
2. High medication costs for some specialty agents (bisphosphonates, compound ketamine preparations)
3. Long treatment duration — CRPS is a chronic condition; the medication record may extend for years
4. Insurance denial risk — some CRPS-specific medications are on specialty drug tiers or are off-label, creating insurance denial scenarios

LienScripts covers the standard CRPS medication portfolio — neuropathic agents, corticosteroids, topical agents, antidepressants, and opioids — when prescribed by a treating physician for documented CRPS. Specialty or compound medications are evaluated individually.

[!NOTE] Some CRPS-specific medications — including bisphosphonates and compound ketamine preparations — may be on specialty drug tiers or prescribed off-label, creating insurance denial scenarios that make pharmacy lien coverage particularly critical for ensuring the patient receives and documents the complete treatment protocol.

[!KEY] CRPS is difficult to diagnose in its early stages — if your client's injury is producing disproportionate burning pain, skin changes, or extreme sensitivity, push for a referral to a pain specialist or neurologist early; delayed diagnosis delays the multi-drug treatment record that supports your damages case.

The Settlement Documentation Picture in CRPS Cases

CRPS is a high-value case category precisely because the injury is serious and the treatment is demanding. A complete pharmacy record in a CRPS case — showing continuous, complex, multi-drug management over an extended period — is powerful evidence of the injury's severity.

[!KEY] Because CRPS is a chronic condition, the pharmacy record may extend for years — ensuring your client has uninterrupted pharmacy lien coverage from initial diagnosis through case resolution prevents treatment gaps that the defense will use to question the severity and continuity of the condition.

For more information on pharmacy lien coverage for complex PI cases, visit for attorneys.

Related Resources

• Pharmacy Services for Personal Injury Clients: How It Works
• Gabapentin for Personal Injury Cases: What Attorneys Need to Know